WeightWatchers soars on saying it will offer compounded version of Novo's Wegovy

WW International

09/10/2024 10:43

** Shares of telehealth firm WeightWatchers  WW.O  surge 37%
at $1.61 premarket
    ** Stock rose 47% to an over two-month closing high on
Tuesday after co said it will offer a compounded version of Novo
Nordisk's  NOVOb.CO  popular weight loss drug Wegovy
    ** Stock, which was above $100 in 2018 has been trading
around $1 since August 2024 as co was struck by revenue
declines, liquidity concerns and Oprah Winfrey's decision to
exit its board
    ** As of last close, stock down ~87% YTD

 (Reporting by Kashish Tandon)
 ((Kashish.tandon@thomsonreuters.com))